$AMGN
Amgen Inc

2023 Q2 Form 10-Q Financial Statement

#000031815423000029 Filed on April 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $6.986B $6.105B $6.238B
YoY Change 5.94% -2.13% 5.71%
Cost Of Revenue $1.813B $1.720B $1.561B
YoY Change 20.07% 10.19% 4.77%
Gross Profit $5.173B $4.385B $4.677B
YoY Change 1.75% -6.24% 6.03%
Gross Profit Margin 74.05% 71.83% 74.98%
Selling, General & Admin $1.294B $1.258B $1.228B
YoY Change -2.49% 2.44% -2.07%
% of Gross Profit 25.01% 28.69% 26.26%
Research & Development $1.113B $1.058B $959.0M
YoY Change 7.12% 10.32% -0.83%
% of Gross Profit 21.52% 24.13% 20.5%
Depreciation & Amortization $896.0M $900.0M $841.0M
YoY Change 8.21% 7.02% 0.0%
% of Gross Profit 17.32% 20.52% 17.98%
Operating Expenses $2.407B $2.316B $2.187B
YoY Change 1.73% 5.9% -1.53%
Operating Profit $2.684B $1.921B $2.500B
YoY Change 23.35% -23.16% 17.43%
Interest Expense -$752.0M -$543.0M -$295.0M
YoY Change 129.27% 84.07% 8.46%
% of Operating Profit -28.02% -28.27% -11.8%
Other Income/Expense, Net -$318.0M $2.064B -$530.0M
YoY Change 0.32% -489.43% -4176.92%
Pretax Income $1.614B $3.442B $1.675B
YoY Change 5.42% 105.49% -9.8%
Income Tax $235.0M $601.0M $199.0M
% Of Pretax Income 14.56% 17.46% 11.88%
Net Earnings $1.379B $2.841B $1.476B
YoY Change 4.71% 92.48% -10.33%
Net Earnings / Revenue 19.74% 46.54% 23.66%
Basic Earnings Per Share $2.58 $5.32 $2.69
Diluted Earnings Per Share $2.57 $5.28 $2.68
COMMON SHARES
Basic Shares Outstanding 534.3M shares 534.0M shares 548.0M shares
Diluted Shares Outstanding 537.0M shares 538.0M shares 551.0M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.20B $31.60B $6.544B
YoY Change 376.12% 382.9% -38.07%
Cash & Equivalents $34.20B $31.60B $6.528B
Short-Term Investments $0.00 $1.000M $16.00M
Other Short-Term Assets $2.324B $2.395B $2.488B
YoY Change 2.92% -3.74% 8.5%
Inventory $4.978B $5.011B $4.411B
Prepaid Expenses
Receivables $5.830B $5.736B $5.077B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $47.38B $44.70B $18.52B
YoY Change 145.21% 141.38% -13.05%
LONG-TERM ASSETS
Property, Plant & Equipment $5.532B $5.460B $5.142B
YoY Change 7.25% 6.18% 5.91%
Goodwill $15.53B $15.53B $14.90B
YoY Change 4.48% 4.26% 1.53%
Intangibles $14.63B $15.39B $14.57B
YoY Change 5.07% 5.67% -8.65%
Long-Term Investments
YoY Change
Other Assets $7.193B $7.633B $6.070B
YoY Change 19.45% 25.75% 5.29%
Total Long-Term Assets $42.89B $44.02B $40.68B
YoY Change 7.3% 8.21% -1.37%
TOTAL ASSETS
Total Short-Term Assets $47.38B $44.70B $18.52B
Total Long-Term Assets $42.89B $44.02B $40.68B
Total Assets $90.27B $88.72B $59.20B
YoY Change 52.24% 49.87% -5.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.212B $1.320B $1.403B
YoY Change -3.5% -5.92% 0.5%
Accrued Expenses $13.72B $12.06B $10.64B
YoY Change 30.09% 13.37% 7.28%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.167B $834.0M $844.0M
YoY Change 165.24% -1.18% -45.76%
Total Short-Term Liabilities $17.10B $14.22B $12.89B
YoY Change 35.5% 10.31% 0.13%
LONG-TERM LIABILITIES
Long-Term Debt $59.38B $60.76B $36.01B
YoY Change 66.3% 68.73% 15.68%
Other Long-Term Liabilities $2.536B $2.532B $2.732B
YoY Change -14.0% -7.32% 25.9%
Total Long-Term Liabilities $61.91B $63.29B $38.74B
YoY Change 60.17% 63.37% 16.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.10B $14.22B $12.89B
Total Long-Term Liabilities $61.91B $63.29B $38.74B
Total Liabilities $79.01B $77.51B $51.63B
YoY Change 54.1% 50.13% 11.83%
SHAREHOLDERS EQUITY
Retained Earnings -$25.54B -$26.92B -$29.57B
YoY Change -9.6% -8.96% 36.64%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.781B $5.348B $916.0M
YoY Change
Total Liabilities & Shareholders Equity $90.27B $88.72B $59.20B
YoY Change 52.24% 49.87% -5.35%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $1.379B $2.841B $1.476B
YoY Change 4.71% 92.48% -10.33%
Depreciation, Depletion And Amortization $896.0M $900.0M $841.0M
YoY Change 8.21% 7.02% 0.0%
Cash From Operating Activities $4.109B $1.064B $2.164B
YoY Change 112.9% -50.83% 2.85%
INVESTING ACTIVITIES
Capital Expenditures $271.0M $344.0M $190.0M
YoY Change -210.16% 81.05% 14.46%
Acquisitions
YoY Change
Other Investing Activities $60.00M -$28.00M -$47.00M
YoY Change -103.08% -40.43% -159.49%
Cash From Investing Activities -$211.0M $1.358B -$111.0M
YoY Change -90.38% -1323.42% -65.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.360B
YoY Change 630.2%
Debt Paid & Issued, Net $704.0M $0.00
YoY Change
Cash From Financing Activities -1.210B $21.51B -$3.514B
YoY Change 13.94% -712.09% 81.23%
NET CHANGE
Cash From Operating Activities 4.109B $1.064B $2.164B
Cash From Investing Activities -211.0M $1.358B -$111.0M
Cash From Financing Activities -1.210B $21.51B -$3.514B
Net Change In Cash 2.688B $23.93B -$1.461B
YoY Change -302.87% -1737.99% 848.7%
FREE CASH FLOW
Cash From Operating Activities $4.109B $1.064B $2.164B
Capital Expenditures $271.0M $344.0M $190.0M
Free Cash Flow $3.838B $720.0M $1.974B
YoY Change 76.38% -63.53% 1.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000318154
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-37702
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Amgen Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-3540776
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
One Amgen Center Drive
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91320-1799
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Thousand Oaks
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei City Area Code
CityAreaCode
805
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
447-1000
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
534326594 shares
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6105000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6238000000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1720000000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1561000000 usd
CY2023Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1058000000 usd
CY2022Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
959000000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1258000000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1228000000 usd
CY2023Q1 amgn Other General Expense Income Other Adjustments
OtherGeneralExpenseIncomeOtherAdjustments
148000000 usd
CY2022Q1 amgn Other General Expense Income Other Adjustments
OtherGeneralExpenseIncomeOtherAdjustments
-10000000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
4184000000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
3738000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1921000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2500000000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
543000000 usd
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
295000000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2064000000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-530000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3442000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1675000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
601000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
199000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2841000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1476000000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.32
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.69
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.28
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.68
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31560000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
534000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
548000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
538000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
551000000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2841000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1476000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
28000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-51000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-86000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
84000000 usd
CY2023Q1 amgn Other Comprehensive Income Loss Other Gains Losses Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossOtherGainsLossesNetOfTaxPortionAttributableToParent
21000000 usd
CY2022Q1 amgn Other Comprehensive Income Loss Other Gains Losses Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossOtherGainsLossesNetOfTaxPortionAttributableToParent
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-37000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
33000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2804000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1509000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7629000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
1000000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
1676000000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5736000000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5563000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
5011000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4930000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
2395000000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2388000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
44703000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
22186000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5460000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5427000000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15393000000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16080000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
15531000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
15529000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7633000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5899000000 usd
CY2023Q1 us-gaap Assets
Assets
88720000000 usd
CY2022Q4 us-gaap Assets
Assets
65121000000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1320000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1572000000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12061000000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12524000000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
834000000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1591000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
14215000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15687000000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
60761000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
37354000000 usd
CY2023Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
5864000000 usd
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
5757000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2532000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2662000000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2750000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2750000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
534300000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
534000000.0 shares
CY2023Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
32535000000 usd
CY2022Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
32514000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26919000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28622000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-268000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-231000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5348000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3661000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
88720000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
65121000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3661000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2841000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-37000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.13
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1138000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
11000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
47000000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
37000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5348000000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6700000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1476000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
33000000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.94
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1034000000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
18000000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
78000000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
45000000 usd
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
6310000000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
916000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2841000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1476000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
900000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
841000000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-49000000 usd
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-251000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
31000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-305000000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1830000000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-211000000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
13000000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-29000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
144000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
195000000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
58000000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
230000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
139000000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
43000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-253000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
42000000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
443000000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
318000000 usd
CY2023Q1 amgn Increase Decrease In Noncurrent Tax Liability
IncreaseDecreaseInNoncurrentTaxLiability
107000000 usd
CY2022Q1 amgn Increase Decrease In Noncurrent Tax Liability
IncreaseDecreaseInNoncurrentTaxLiability
57000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-710000000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-396000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1064000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2164000000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1124000000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
550000000 usd
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
32000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
344000000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
190000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-28000000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-47000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1358000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-111000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
23798000000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3952000000 usd
CY2023Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
420000000 usd
CY2022Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
704000000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6360000000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1137000000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1080000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-28000000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-26000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21509000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3514000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23931000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1461000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7629000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7989000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31560000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6528000000 usd
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results may differ from those estimates.</span></div>
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9400000000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9300000000 usd
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
132000000 usd
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6105000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6238000000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.175
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.119
CY2023Q1 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
60000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2841000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1476000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
534000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
548000000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4000000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
538000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
551000000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.32
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.69
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.28
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.68
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
31065000000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
31065000000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4335000000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4335000000 usd
CY2023Q1 us-gaap Cash
Cash
496000000 usd
CY2022Q4 us-gaap Cash
Cash
4970000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31600000000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
5000000 usd
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-170000000 usd
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
903000000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
828000000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2978000000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3098000000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1130000000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1004000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
5011000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4930000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
15529000000 usd
CY2023Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-4000000 usd
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
6000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
15531000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
35615000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21231000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14384000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
35596000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20525000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15071000000 usd
CY2023Q1 amgn Identifiable Intangible Assets Gross
IdentifiableIntangibleAssetsGross
36624000000 usd
CY2023Q1 amgn Identifiable Intangible Assets Accumulated Amortization
IdentifiableIntangibleAssetsAccumulatedAmortization
21231000000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15393000000 usd
CY2022Q4 amgn Identifiable Intangible Assets Gross
IdentifiableIntangibleAssetsGross
36605000000 usd
CY2022Q4 amgn Identifiable Intangible Assets Accumulated Amortization
IdentifiableIntangibleAssetsAccumulatedAmortization
20525000000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16080000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
693000000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
637000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2100000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2700000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2500000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2200000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2100000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1100000000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1434000000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1246000000 usd
CY2023Q1 us-gaap Hedged Liability Fair Value Hedge Cumulative Increase Decrease
HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
-343000000 usd
CY2022Q4 us-gaap Hedged Liability Fair Value Hedge Cumulative Increase Decrease
HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
-437000000 usd
CY2023Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
12000000 usd
CY2022Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
12000000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
61595000000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
38945000000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
834000000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1591000000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
60761000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
37354000000 usd
CY2023Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
24000000000 usd
CY2023Q1 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
420000000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
113000000 usd
CY2023Q1 us-gaap Line Of Credit Facility Commitment Fee Percentage
LineOfCreditFacilityCommitmentFeePercentage
0.0009
CY2022Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 usd
CY2021Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
24600000 shares
CY2021Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5410000000 usd
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
7000000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.13
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.13
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
2.13
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
5621000000 usd
CY2023Q1 us-gaap Other Investments
OtherInvestments
131000000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
4833000000 usd
CY2023Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
36281000000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
273000000 usd
CY2023Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1525000000 usd
CY2022Q4 us-gaap Other Investments
OtherInvestments
130000000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
815000000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
270000000 usd
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1668000000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
270000000 usd
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
342000000 usd
CY2023Q1 amgn Business Combination Contingent Consideration Arrangements Payments
BusinessCombinationContingentConsiderationArrangementsPayments
2000000 usd
CY2022Q1 amgn Business Combination Contingent Consideration Arrangements Payments
BusinessCombinationContingentConsiderationArrangementsPayments
2000000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
5000000 usd
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-10000000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
273000000 usd
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
330000000 usd
CY2023Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
59800000000 usd
CY2022Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
35000000000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
61600000000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
38900000000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2064000000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
543000000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-530000000 usd
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
295000000 usd
CY2023Q1 us-gaap Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
97000000 usd
CY2023Q1 us-gaap Derivative Assets
DerivativeAssets
252000000 usd
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
1252000000 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
341000000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1398000000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
61600000000 usd
CY2023Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
59800000000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
38900000000 usd
CY2022Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
35000000000 usd

Files In Submission

Name View Source Status
amgn-20230331_cal.xml Edgar Link unprocessable
0000318154-23-000029-index-headers.html Edgar Link pending
0000318154-23-000029-index.html Edgar Link pending
0000318154-23-000029.txt Edgar Link pending
0000318154-23-000029-xbrl.zip Edgar Link pending
amgn-20230331.htm Edgar Link pending
amgn-20230331.xsd Edgar Link pending
amgn-ex31_2023331xq1.htm Edgar Link pending
amgn-ex32_2023331xq1.htm Edgar Link pending
exhibit10202-secondamendme.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
amgn-20230331_def.xml Edgar Link unprocessable
amgn-20230331_lab.xml Edgar Link unprocessable
amgn-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
amgn-20230331_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending